Vanguard Fiduciary Trust
IMUX icon

Vanguard Fiduciary Trust’s Immunic IMUX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
82,029
+7,975
+11% +$98.4K ﹤0.01% 2928
2026
Q1 		$822K Buy
+74,054
New +$663K ﹤0.01% 3010

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Fiduciary Trust's IMUX Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Immunic (IMUX) stake by 11% in Q2 2026, buying an estimated $98.4K and bringing the position to 82,029 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2928.

Vanguard Fiduciary Trust first reported a position in IMUX in Q1 2026 and has held it in 2 quarters since. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Vanguard Fiduciary Trust held 82,029 shares of Immunic worth $1.26M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 7,975 Immunic shares in Q2 2026, an estimated $98.4K.
  • Immunic made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2928 holding.
  • Vanguard Fiduciary Trust first reported a position in Immunic in Q1 2026 and has held it in 2 quarters since.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.